Multiple Sclerosis Therapeutics Market to Reach US$ 24.4 Billion with a CAGR of 2.5% by 2030 | Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A. |
Damage to the protective coverings of nerve cells in the brain and spinal cord is what causes multiple sclerosis (MS), a demyelinating disease. Several